September 20, 2026

Four firms in my category promise you the same thing. You will know which of your deals are real. I spent this fortnight reading all four sites end to end, around 420,000 words, looking for the words you would need to do that. They are not there.
I work with B2B tech founders at the 5 to 100 person stage who are still running the revenue motion themselves, so reading what the category publishes is part of the job. I went in to see how they describe their method, every page of every site. What I found instead is the reason I am writing this rather than the piece I had planned.
These are the terms I searched for. Deal review. Win rate. Close rate. Economic buyer. Buying group. Root cause.
Across 14 pages on one site, 359,346 characters, none of them appeared. Not once. On another, seven pages, the same result, next to a headline selling a method that tells you which deals are real. The third ran to roughly 40,000 words and called its diagnostic an architecture audit. The fourth published 22 pages and a weekly client report that ends at meetings booked.
Four independent sites, and the same absence on all of them.
That could be a coincidence of house style. It could also be something that costs founders money.
If you have bought one of these, you were not careless. The sites are good. The arguments are well made and the diagnosis is often right. I have read them closely enough to say that honestly, and I have written pages that had the same hole in them.
Here is what I think is going on.
A method that tells you which deals are real has to contain an instrument. Something that can be pointed at one specific deal, this week, and come back with an answer that contradicts what you hoped. The instrument is the uncomfortable part. It is also the part that produces the promise.
What gets published instead is the architecture. The stages, the ICP definition, the journey map, the sequence. All of it real work. None of it capable of telling you that the deal you like is dead.
So the founder buys a structure and expects an answer. The structure arrives. The answer does not. And because the structure is better than what was there before, nobody can tell whether the method failed or whether the quarter just went badly.
Take the three deals you would name if an investor asked what is closing this quarter.
For each one, write down who signed off on the budget, and how you know. Not who told you they would champion it. Who controls the money, and what evidence you have that they know your name.
If you can answer for all three, your pipeline is better than most of what I inspect. If you can answer for one, you have found the thing your method was supposed to find.
Nothing dramatic. A founder I worked with runs a twenty minute review every Thursday against four questions. The questions never change. About a third of the time, a deal moves backwards in that meeting.
That is the signal that the instrument is live. A review where everything holds its position is a status update with a calendar invite.
The forecast gets smaller. Then it starts being right.
One of the four is honest about it. Their product is top of funnel. They manufacture meetings, they say so plainly, and their report ends where their responsibility ends. If the promise is meetings, no inspection layer is owed.
The problem is the firms whose promise runs all the way to closed revenue and whose published method stops at the same place.
I write about this three times a week on LinkedIn. Each post that week took one piece of this further: what happens when a methodology is shipped before it is finished, why an installed position needs a trigger to revisit it, and why an operating layer beats a reporting line.